The FDA’s PAT (Process Analytical Technology) initiative has enabled GEA to combine its equipment design skills and process engineering know-how in order to integrate online analyzers and measurement devices into its process systems in a way which can provide real insight into the operation of the process and help customers achieve key product quality target.
Showing 4 of 9
This standalone module allows you to start developing your PAT models for a pharmaceutical continuous manufacturing process offline during the early stages of R&D.
Based on the traditional concept of a live coal-mine canary, the 21st century equivalent from GEA is a continuous real-time monitoring system that’s been designed to detect breaches in contained pharmaceutical production lines. By providing an additional level of monitoring, the Digital Canary reduces the need for routine occupational health chec...
The Lighthouse Probe® can be used for real-time monitoring of chemical and pharmaceutical processes and provides in-process window cleaning at any time, recalibration during the process, full CIP (cleaning) of wash housing and seal, and a clear view inside – even in difficult conditions.
LYOSENSE® from GEA, based on multipoint NIR measurements, provides the comprehensive and non-destructive evaluation of freeze-dried product cakes in real-time.
GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and plants as well as advanced process technology, components and comprehensive services. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.
GEA is listed in the German MDAX and the STOXX® Europe 600 Index and is also among the companies comprising the DAX 50 ESG and MSCI Global Sustainability Indices.
© GEA Group Aktiengesellschaft 2024Cookie settings